Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Cello Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Cello Therapeutics

Cello Therapeutics

Series A

Nanoparticle developer specializing in cancer treatment solutions.

HQ
San Diego, CA, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize cancer treatment, Cello Therapeutics specializes in the development of advanced nanoparticle-based therapies. The company focuses on creating innovative nanomedicines designed to enhance the efficacy and reduce the side effects of chemotherapy and immunotherapy. By leveraging cutting-edge technology, Cello aims to provide more effective and targeted cancer treatments, addressing a critical need in the oncology market.

Cello Therapeutics has garnered attention from notable investors and industry experts due to its groundbreaking approach. The company has achieved significant milestones, including securing patents for its proprietary nanoparticle technologies and publishing influential research in leading scientific journals. Cello's impact is marked by its potential to significantly improve cancer treatment outcomes, offering hope to millions of patients worldwide.

Cello Therapeutics - Similar Companies

Cellics Therapeutics logo

Cellics Therapeutics

cellics.com

Nanocan Therapeutics logo

Nanocan Therapeutics

Telo Therapeutics logo

Telo Therapeutics

PNP Therapeutics logo

PNP Therapeutics

Cellerant Therapeutics logo

Cellerant Therapeutics

Palm Therapeutics logo

Palm Therapeutics

NanoPharmaceuticals logo

NanoPharmaceuticals

Cellective BioTherapy logo

Cellective BioTherapy

SynerGene Therapeutics logo

SynerGene Therapeutics

Cellevolve Bio logo

Cellevolve Bio

cellevolve.com

Vali Nanomedical logo

Vali Nanomedical

Advanced NanoTherapies logo

Advanced NanoTherapies

Nanospectra Biosciences logo

Nanospectra Biosciences

nanospectra.com

Elucida Oncology logo

Elucida Oncology

Century Therapeutics logo

Century Therapeutics

centurytx.com

Cello Therapeutics - Quick Facts

Who are Cello Therapeutics' competitors?

Companies similar to Cello Therapeutics include Cellics Therapeutics, Nanocan Therapeutics, Telo Therapeutics and PNP Therapeutics.

When was Cello Therapeutics founded?

Cello Therapeutics was founded in 2016.

Where is Cello Therapeutics' headquarters located?

Cello Therapeutics' headquarters is located in San Diego, CA, US.

When was Cello Therapeutics' last funding round?

Cello Therapeutics' most recent funding round was for $7.1M (USD) in August 2022.

How much has Cello Therapeutics raised to-date?

As of Aug 22, 2022, Cello Therapeutics has raised a total of $8.7M (USD).

How many employees does Cello Therapeutics have?

Cello Therapeutics has 8 employees as of Feb 5, 2024.

Cello Therapeutics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Nanotechnology
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Treatment
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified